Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 34, 2004 - Issue 4
Submit an article Journal homepage
148
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man

B. K. Wong Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USACorrespondence[email protected]
,
X. Xu Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
,
S. Yu Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
,
J. H. Lin Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
,
R. Singh Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
,
Y. Sahly Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
,
G. Mistry Department of Clinical Pharmacology, Merck Research Laboratories, Rahway, NJ, USA
,
S. Holland Department of Clinical Pharmacology, Merck Research Laboratories, Rahway, NJ, USA
,
S. Waldman Department of Clinical Pharmacology, Thomas Jefferson University, Philadelphia, PA, USA
,
D. Musson Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
&
A. Majumdar Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA
 show all
Pages 379-389 | Received 06 Nov 2003, Published online: 22 Sep 2008

Reference

  • ADACHI, H., KUBOTA, I., OKAMURA, N., IWATA, H., TSUJIMOTO, M., NAKAZATO, H., NISHIHARA, T. and NOGUCHI, T., 1989, Purification and characterization of human microsomal dipeptidase. Journal of Biochemistry, 105, 957–961.
  • ANON., 2002, Ertapenem (INVANZ) - a new parenteral carbapenems. Medical Letter, 44, 25-26. BURMAN, L. A., NILSSON-EHLE, I., HUTCHISON, M., HAWORTH, S. J. and NORRBY, S. R., 1991, Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. Journal of Antimicrobial Chemotherapy, 27, 219–224.
  • GIBALDI, M. and PERRIER, D., 1982, Pharmacokinetics, 2nd edn (New York: Marcel-Dekker).
  • GILL, C. J., JACKSON, J. J., GERCKENS, L. S., PELAK, B. A., THOMPSON, R. K., SUNDELOF, J. G., KRoPP, H. and ROSEN, H, 1998, In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrobial Agents and Chemotherapy, 42, 1996–2001.
  • HARRISON, M. P., HAWORTH, S. J., MOSS, S. R., WILKINSON D. M. and FEATHERSTONE, A., 1993, The disposition and metabolic fate of meropenem. Xenobiotica, 23, 1311–1323.
  • HARRISON, M. P., Moss, S. R., FEATHERSTONE, A., FOWKES, A. G., SANDERS A. M. and CASE, D. E., 1989, The disposition and metabolism of meropenem in laboratory animals and man. Journal of Antimicrobial Chemotherapy, 24 (Suppl. A), 265–277.
  • HOLLAND, S. D., MAJUMDAR, A., FISHER A., MUSSON, D., SWAN, S., SICA, D., DEUTSCH, P., MISTRY, G. C. and BIRK, K., 2001, Pharmacokinetics of ertapenem sodium in renal insufficiency (abstract). Clinical Pharmacology and Therapy, 69, P16.
  • HOP, C. E., Yu, X., Xu, X., SINGH, R. and WONG, B. K., 2001, Elucidation of fragmentation mechanisms involving transfer of three hydrogen atoms using a quadrupole time-of-flight mass spectrometer. Journal of Mass Spectrometry, 36, 575–579.
  • KAHAN, F. M., KROPP, H., SUNDELOF J. G. and BIRMBAUM, J., 1983, Thienamycin: development of imipenem-cilastatin. Journal of Antimicrobial Chemotherapy, 12 (Suppl), 1–35.
  • KROPP, H., SUNDELOF, J. G., HAJDU R. and KAHAN, F. M., 1982, Metabolism of thienamycin and related carbapenem antibiotics by the renal dehydropeptidase-I. Antimicrobial Agents and Chemotherapy, 22, 62–70.
  • KUDO, S., 1994, Differentiation of Clara cells and pneumocytes of the rat by means of enzyme- and immunohistochemistry. Anatomical Record, 238, 49–56.
  • MAJUMDAR, A. K., MUSSON, D. G., BIRK, K. L., KITCHEN, C. J., HOLLAND, S., MCCREA, J., MISTRY, G., HESNEY, M., XI, L., LI, S. X., HAESEN, R., BLUM, R. A., LINS, R. L., GREENBERG, H., WALDMAN, S., DEUTSCH, P. and ROGERS, J. D, 2002, Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrobial Agents and Chemotherapy, 46, 3506–3511.
  • MUSSON, D. G., BIRK, K. L., CAIRNS, A. M., MAJUMDAR, A. K. and ROGERS, J. D., 1998, High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine. Journal of Chromatography - B: Biomedicine, 720, 99–106.
  • NORRBY, S. R., ALESTIG, K., BJORNEGARD, B., BURMAN, L. A., FERBER, F., HUBER, J. L., JONES, K. H., KAHAN, F. M., KROPP, H., MEISINGER, M. A. P. and SUNDELOF, J. G., 1983, Urinary recovery of N-formimoyl (MK0787) as affected by coadministration of N-formimoyl thienamycin dehydropeptidase inhibitors. Antimicrobial Agents and Chemotherapy, 23, 300–307.
  • ORTiz-Ruiz, G., CABALLERO-LOPEZ, J., FRIEDLAND, I. R., WOODS, G. L. and CARIDES, A, 2002, A study evaluating the efficacy, safety, and tolerability of ertapenem vs ceftriaxone for the treatment of community-acquired pneumonia in adults. Clinical Infection and Disease, 34, 1076–1083.
  • UCHIDA, T. and O'BRIEN, R. D., 1967, Dimethoate degradation by human liver and its significance for acute toxicity. Toxicology and Applied Pharmacology, 10, 89–94.
  • WONG, B. K., BRUHIN, P. J. and LIN, J. H., 1999, Dose-dependent plasma clearance of MK-826, a carbapenem antibiotic in rats and monkeys arising from concentration-dependent plasma protein binding. Journal of Pharmaceutical Sciences, 88, 277–280,
  • YELLIN, A. E., HASSETT, J. M., FERNANDEZ, A. GEIB, J., ADEYI, B., WOODS, G. L. and TEPPLER, H., 2002, Ertapenem monotherapy vs. combination therapy with ceftriaxone plus metranidazole for treatment of complicated intra-abdominal infections in adults. International Journal of Antimicrobial Agents, 20, 165–173.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.